Initiating Coverage of Max Sound Corp. (MAXD) with Speculative Buy $2.50 2014 Target

At NBT Equities Research we are always looking for the game-changing next big thing technology or company—it’s what we do.

NBT Equities Research and NBT Capital Markets LLC along with LD Micro, Sidoti Capital and Roth Capital Partners LLC are sponsoring "Top 100 Emerging Growth Microcaps 2013." Our goal is to identify and recognize the best-of-the-best emerging growth companies in the mostly invisible <$250 million market cap asset class.

We will be interviewing hundreds of companies during our search period...and analyzing hundreds more with our proprietary Next Big Thing Microcap Ratings™ analytics protocols.

Pulse Beverage’s Advisory Board Member, Dr. Pam Peeke, MD, MPH, FACP, now has a  NY Times Bestseller, “The Hunger Fix”. Dr. Peeke is an internationally recognized expert, physician, scientist and author in the fields of nutrition, stress, fitness and public health.

With the announced completion of an additional $1.7 million in financing, GlyEco (GLYE) has raised $6.2 million to maintain its rapid consolidation strategy of the multi-$billion glycol recycling space. GlyEco plans to use the proceeds from this offering to accelerate its aggressive growth plan, including investments in initial facility upgrades and increased processing capacity.

More success from Pulse has been announced today. They have completed the initial production of their Health Formula Functional Beverage Line. With the success of their Cabana™ 100% Natural Lemonade, Pulse plans on making repeat success with their three different heath platforms: PULSE® - Women’s Health Formula™, PULSE® - Men’s Health Formula™ and PULSE® Heart Health Formula™.

While I was relaxing here at the 12th annual Wine, Dine and Stocks Adventure, I came across an email that I felt should be seen by our NBT readers. A friend of NBT and Seeking Alpha Blogger Wes Stull has written a very interesting read on how VelaTel can push forward in 2013. From it's early days when VelaTel merged with Chinacomm to its recent headlines, this article looks at the details and helps makes the case for VelaTel and a STRONG potential comeback in 2013.

Greetings from Cape Town South Africa

Greetings from Cape Town South Africa where the summer warmth has made for a timely escape from the chilly Northeast. We are with a group of NBT friends and family for our 12th annual Wine, Dine and Stocks Adventure…judging by the first few days of laughter this year is going to be tough to beat. FULL report on our wine and dine discoveries to follow!

Adding Oregon, Northern Idaho, and Eastern/Western Washington State plugs one of the final holes in Pulse’s distribution network and another 12 million thirsty people to their distribution footprint.

Our colleague Rob Goldman of Goldman Research published a nice report on Pulse Beverage today. As usual…people tweeted and posted that research was started by Goldman Sachs on Pulse…just wanted to clear this mild confusion up.

Rob makes a good comparison that PLSB is “Clearly Canadian II”—with Bob Yates and Bruce Horton from Clearly Canadian fame running the show.

Our celebrity beauty licensing company Boldface Group announced this week that CVS/pharmacy® has expanded the Beauty Brand's presence to 2100 key beauty doors after a successful initial launch of the Company's limited edition Holiday line.

CVS is one of the KEY retail stores for cosmetics in United States—it’s the store that launched Selma Hayek’s Nuance $100 million cosmetic line—they CLEARLY know how to sell celebrity cosmetics to their customer.

Here is the business plan BLBK has used to raise $5 million in equity. We can hardly wait for a financial forecast updated for the new accounts.

BoldFace Investor Presentation

Disclaimer

We investors in Pulse Beverage continue to be surprised to the UPSIDE with the rapid ramp in sales and global distribution for Pulse Beverage (PLSB). Quarterly sales growth is only 267,215.70%!

By raising their 12-Month sales forecast to 3 million cases including 500k cases for just released PULSE® brand functional beverages we go back to the drawing board on our current valuation and 2013-2015 sales forecast.

We are initiating coverage of BOLDFACE Group, Inc. with a Speculative Buy Rating and $1.50 target price on 87.4MM million shares fully diluted and 5 X DPV of 2015 NBT revenue forecast of @$40 million.

Investment Thesis:

How We Will Select our 2013 NBT Equities Research Emerging Growth Portfolio (Hint: Look at PLSB!)

#1 Question I get these days is “How do you find and select NBT Emerging Growth Portfolio?”

Moral of this story? IF you have a real experienced management team AND they work their tails off AND you have a superior product good things happen for shareholders!

Pulse filed their 10-Q Quarterly Report for shareholders and the market obviously focused on one key remark: